Pancreatic Cancer
Background: Types: Pancreatic ductal adenocarcinoma (PDAC): 85–95% KRAS mutations are found in ~90% of PDAC Neuroendocrine tumors, Acinar cell carcinomas, Cystic neoplasms: 1-5% Rare Variants: Adenosquamous carcinoma, colloid carcinoma, etc: <1% Work up: EUS/ERCP for biopsy and stent placement Consult GI for ERCP if bilirubin high (prior to giving chemotherapy) CT Chest/Abdomen/Pelvis CA 19-9 (baseline) CA19-9 is a good marker but should not be used to determine need for trea